Role of Multiomics Data to Understand Host-Pathogen Interactions in COVID-19 Pathogenesis
- PMID: 33426872
- DOI: 10.1021/acs.jproteome.0c00771
Role of Multiomics Data to Understand Host-Pathogen Interactions in COVID-19 Pathogenesis
Abstract
Human infectious diseases are contributed equally by the host immune system's efficiency and any pathogens' infectivity. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the coronavirus strain causing the respiratory pandemic coronavirus disease 2019 (COVID-19). To understand the pathobiology of SARS-CoV-2, one needs to unravel the intricacies of host immune response to the virus, the viral pathogen's mode of transmission, and alterations in specific biological pathways in the host allowing viral survival. This review critically analyzes recent research using high-throughput "omics" technologies (including proteomics and metabolomics) on various biospecimens that allow an increased understanding of the pathobiology of SARS-CoV-2 in humans. The altered biomolecule profile facilitates an understanding of altered biological pathways. Further, we have performed a meta-analysis of significantly altered biomolecular profiles in COVID-19 patients using bioinformatics tools. Our analysis deciphered alterations in the immune response, fatty acid, and amino acid metabolism and other pathways that cumulatively result in COVID-19 disease, including symptoms such as hyperglycemic and hypoxic sequelae.
Keywords: COVID-19; SARS-CoV-2; altered biomolecules; immune response; mass spectrometry; metabolomics; pathways; proteome microarray; proteomics.
Similar articles
-
COVIDomics: The Proteomic and Metabolomic Signatures of COVID-19.Int J Mol Sci. 2022 Feb 22;23(5):2414. doi: 10.3390/ijms23052414. Int J Mol Sci. 2022. PMID: 35269564 Free PMC article. Review.
-
Proteomic Approaches to Study SARS-CoV-2 Biology and COVID-19 Pathology.J Proteome Res. 2021 Feb 5;20(2):1133-1152. doi: 10.1021/acs.jproteome.0c00764. Epub 2021 Jan 19. J Proteome Res. 2021. PMID: 33464917 Free PMC article.
-
Multiomics: unraveling the panoramic landscapes of SARS-CoV-2 infection.Cell Mol Immunol. 2021 Oct;18(10):2313-2324. doi: 10.1038/s41423-021-00754-0. Epub 2021 Sep 1. Cell Mol Immunol. 2021. PMID: 34471261 Free PMC article. Review.
-
Multiomics integration-based molecular characterizations of COVID-19.Brief Bioinform. 2022 Jan 17;23(1):bbab485. doi: 10.1093/bib/bbab485. Brief Bioinform. 2022. PMID: 34864875 Free PMC article. Review.
-
COVID-19 Pandemic: Hopes from Proteomics and Multiomics Research.OMICS. 2020 Aug;24(8):457-459. doi: 10.1089/omi.2020.0073. Epub 2020 May 18. OMICS. 2020. PMID: 32427517
Cited by
-
Mumbai mayhem of COVID-19 pandemic reveals important factors that influence susceptibility to infection.EClinicalMedicine. 2021 May;35:100841. doi: 10.1016/j.eclinm.2021.100841. Epub 2021 Apr 25. EClinicalMedicine. 2021. PMID: 33937730 Free PMC article.
-
Metabolomics study of COVID-19 patients in four different clinical stages.Sci Rep. 2022 Jan 31;12(1):1650. doi: 10.1038/s41598-022-05667-0. Sci Rep. 2022. PMID: 35102215 Free PMC article.
-
Drug repositioning via host-pathogen protein-protein interactions for the treatment of cervical cancer.Front Oncol. 2023 Jan 25;13:1096081. doi: 10.3389/fonc.2023.1096081. eCollection 2023. Front Oncol. 2023. PMID: 36761959 Free PMC article.
-
A data-mining analysis of host solute carrier family proteins in SARS-CoV-2 infection with reference to brain endothelial cells and the blood-brain barrier in COVID-19.Front Neurol. 2025 Jul 1;16:1563040. doi: 10.3389/fneur.2025.1563040. eCollection 2025. Front Neurol. 2025. PMID: 40667466 Free PMC article.
-
Unraveling metabolic signatures in SARS-CoV-2 variant infections using multiomics analysis.Front Immunol. 2024 Dec 11;15:1473895. doi: 10.3389/fimmu.2024.1473895. eCollection 2024. Front Immunol. 2024. PMID: 39759510 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
